TB551

N/A

Report date: 2026/05/20 20:02:01

NMEFirst In Class

Base Information

Drug NameTB551

Drug Alias NameTB551TB-551TB522TB-522

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Small molecules > Synthetic peptide > Circular polypeptide

Mechanisms of ActionF1 capsule antigen modulators

TargetsF1 capsule antigen

Therapy Area/IndicationsSolid tumoursPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTwinpig Biolab Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursPancreatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A